Clinical Trial Update: The Role of Secondary Bile Acids in Intestinal Inflammation [Phase 2, Phase 3]

View source ↗

Summary

A Stanford-sponsored Phase 2/Phase 3 trial evaluating secondary bile acids for intestinal inflammation in ulcerative colitis and pouchitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pouchitis
• Ulcerative Colitis

Snippet

Sponsor: Stanford University | Conditions: Ulcerative Colitis, Pouchitis | Phase 2, Phase 3 | Status: TERMINATED